Form 4: Labcorp Executive Jonathan P. DiVincenzo Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Jonathan P. DiVincenzo, EVP, Pres, Central Labs & Intl at Laboratory Corp of America Holdings, reports the vesting and subsequent transactions of restricted stock units.

Summary

  • On March 27, 2024, Jonathan P. DiVincenzo, an executive at Laboratory Corp of America Holdings (Labcorp), had 3,012 Restricted Stock Units (RSUs) vest.
  • These RSUs were converted from performance awards granted in 2021 and fully vested due to the spin-off of Fortrea Holdings Inc.
  • DiVincenzo also disposed of 952 shares to cover tax obligations at a price of $216.57 per share.
  • Following these transactions, DiVincenzo directly owns 5,460.5491 shares of Labcorp common stock and 1,965 RSUs.

Sentiment

Score: 5

Explanation: The document simply reports stock transactions, so the sentiment is neutral.

Industry Context

Executive stock transactions are a routine part of corporate governance and provide insights into management's perspective on the company's performance and future prospects. This transaction is related to equity awards granted in the past and adjusted due to a corporate spin-off.

Stakeholder Impact

  • The transactions have a minimal direct impact on stakeholders, as they are part of standard executive compensation practices.

Key Dates

DateDescription
03/27/2024Restricted Stock Units vested and shares were disposed of for tax obligations.
03/29/2024Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.